World Health Organization (WHO) plans to receive complete data on the Russian vaccine against coronavirus Sputnik V by the end of January. This was stated by the assistant to the general director of the organization, Marianjela Simao, reports TASS .
She noted that since October last year, WHO has received 13 proposals to add vaccines to the list for use in an emergency. This list, she clarified, includes drugs from companies Pfizer / BioNTech and Chinese Sinopharm.
Simao explained that WHO’s evaluation of these vaccines allows the procurement of drugs by international organizations such as UNICEF .
Sputnik V was developed by the Russian Gamaleya Research Center for Electrochemistry and became the world’s first officially registered vaccine against coronavirus. Later, the Russian Ministry of Health registered another drug – EpiVacCorona, developed by the center Rospotrebnadzor “Vector”. On December 5, Moscow started vaccination against coronavirus with Sputnik V. In the United States, they began to inoculate the population with drugs from Pfizer / BioNTech and Moderna. Pfizer and AstraZeneca vaccines have been approved in the UK.